Immediate Impact

15 from Science/Nature 59 standout
Sub-graph 1 of 25

Citing Papers

Looking beyond COVID-19 vaccine phase 3 trials
2021 Standout
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
2019 Standout
2 intermediate papers

Works of Jan Gerstoft being referenced

Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA
2001
Development of resistance to zidovudine (ZDV) and didanosine (ddl) in HIV from patients in ZDV, ddl and alternating ZDV/ddl therapy
1996

Author Peers

Author Last Decade Papers Cites
Jan Gerstoft 193 143 73 4 230
Samuel Ferret 108 102 38 7 177
Andrew N. Phillips 179 82 146 4 251
Concepción Cepeda 227 155 29 5 252
J. A. McCutchan 118 61 127 8 185
Kathy Melbourne 178 92 87 5 294
V. Daneluzzi 68 62 86 6 138
Joel E. Gallant 166 94 151 8 271
José Manuel Hermida 147 116 95 10 263
S M Forster 110 82 181 6 283
Jesús Santos 149 105 25 6 191

All Works

Loading papers...

Rankless by CCL
2026